Johnson & Johnson announces launch of Varipulse Pro in Europe

Johnson & Johnson announced the launch of Varipulse Pro in Europe following CE Mark approval, further advancing its pulsed field ablation portfolio. This new pulse sequence marks the next evolution of the Varipulse Platform and is designed to improve procedural efficiencyi,ii while reinforcing its established safetyiii and effectivenessiv profile. “The introduction of VARIPULSE Pro in Europe reflects our commitment to advancing our PFA platforms through continuous innovation, enhancing procedural experience while maintaining the consistency and precision physicians expect from the VARIPULSE Platform,” said Michael Bodner, Company Group Chair, Electrophysiology & Neurovascular, MedTech, Johnson & Johnson. “This launch demonstrates our dedication to continuously evolving PFA technologies based on real-world learnings and our scientific expertise, supporting physicians to deliver high-quality care and improved patient outcomes.”